Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats

被引:150
作者
Frozza, Rudimar L. [1 ]
Bernardi, Andressa [2 ]
Paese, Karina [2 ]
Hoppe, Juliana B. [1 ]
da Silva, Thaline [1 ]
Battastini, Ana M. O. [1 ]
Pohlmann, Adriana R. [2 ,3 ]
Guterres, Silvia S. [2 ]
Salbego, Christianne [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Farmaceut, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Programa Posgrad Quim, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil
关键词
trans-Resveratrol; Nanocapsule; Drug Delivery; Physical Stability; Biodistribution; BLOOD-BRAIN-BARRIER; TARGETED DELIVERY; SMALL-INTESTINE; NANOPARTICLES; BIOAVAILABILITY; INSTABILITY; METABOLISM; ABSORPTION; PARTICLES; PEPTIDES;
D O I
10.1166/jbn.2010.1161
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Several studies have reported that orally ingested trans-resveratrol is extensively metabolized in the enterocyte before it enters the blood and target organs. Additionally, trans-resveratrol is photosensitive, easily oxidized and presents unfavorable pharmacokinetics. Therefore, it is of great interest to stabilize trans-resveratrol in order to preserve its biological activities and to improve its bioavailability in the brain. Here, trans-resveratrol was loaded into lipid-core nanocapsules and analyzed for particle size, polydispersity and zeta potential. The nanocapsule distribution in brain tissue was evaluated by intraperitoneal (i.p.) and gavage routes in healthy rats. The lipid-core nanocapsules had a mean diameter of 241 nm, a polydispersity index of 0.2, and a zeta potential of -15 mV. No physical changes were observed after 1, 2 and 3 months of storage at 25 degrees C. Lipid-core nanocapsules showed high entrapment of trans-resveratrol and displayed a higher trans-resveratrol concentration in the brain, the liver and the kidney after daily i.p. or gavage administration than that observed for the free trans-resveratrol. Because trans-resveratrol is a potent cyclooxygenase-1 inhibitor, gastrointestinal damage was evaluated. The animals that were administered with trans-resveratrol-loaded lipid-core nanocapsules showed significantly less damage when compared to those administered with free trans-resveratrol. In summary, lipid-core nanocapsules exhibited great trans-resveratrol encapsulation efficiency. trans-Resveratrol-loaded lipid-core nanocapsules increased the concentration of trans-resveratrol in the brain tissue. Gastrointestinal safety was improved when compared with free trans-resveratrol. Thus, trans-resveratrol-loaded lipid-core nanocapsules may be used as an alternative potential therapeutic for several diseases including Alzheimer's disease.
引用
收藏
页码:694 / 703
页数:10
相关论文
共 39 条
  • [11] Distribution of [3H]trans-resveratrol in rat tissues following oral administration
    El-Mohsen, Manal Abd
    Bayele, Henry
    Kuhnle, Gunter
    Gibson, Glenn
    Debnam, Edward
    Srai, S. Kaila
    Rice-Evans, Catherine
    Spencer, Jeremy P. E.
    [J]. BRITISH JOURNAL OF NUTRITION, 2006, 96 (01) : 62 - 70
  • [12] PHARMACOKINETICS AND DISTRIBUTION OF A BIODEGRADABLE DRUG-CARRIER
    GRISLAIN, L
    COUVREUR, P
    LENAERTS, V
    ROLAND, M
    DEPREZDECAMPENEERE, D
    SPEISER, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (03) : 335 - 345
  • [13] Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles
    Gulyaev, AE
    Gelperina, SE
    Skidan, IN
    Antropov, AS
    Kivman, GY
    Kreuter, J
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (10) : 1564 - 1569
  • [14] Guterres SS, 2001, STP PHARMA SCI, V11, P229
  • [15] Biodegradable nanoparticles for drug delivery and targeting
    Hans, ML
    Lowman, AM
    [J]. CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE, 2002, 6 (04) : 319 - 327
  • [16] Sustained Release from Lipid-Core Nanocapsules by Varying the Core Viscosity and the Particle Surface Area
    Jager, Eliezer
    Venturini, Cristina G.
    Poletto, Fernanda S.
    Colome, Leticia M.
    Pohlmann, Joao P. U.
    Bernardi, Andressa
    Battastini, Ana M. O.
    Guterres, Silvia S.
    Pohlmann, Adriana R.
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (01) : 130 - 140
  • [17] Juan M.E., 2009, J PHARM BIOMED ANAL, V51, P391, DOI DOI 10.1016/J.JPBA.2009.03.026
  • [18] The daily oral administration, of high doses of trans-resveratrol to rats for 28 days is not harmful
    Juan, ME
    Vinardell, MP
    Planas, JM
    [J]. JOURNAL OF NUTRITION, 2002, 132 (02) : 257 - 260
  • [19] PASSAGE OF PEPTIDES THROUGH THE BLOOD-BRAIN-BARRIER WITH COLLOIDAL POLYMER PARTICLES (NANOPARTICLES)
    KREUTER, J
    ALYAUTDIN, RN
    KHARKEVICH, DA
    IVANOV, AA
    [J]. BRAIN RESEARCH, 1995, 674 (01) : 171 - 174
  • [20] Resveratrol is absorbed in the small intestine as resveratrol glucuronide
    Kuhnle, G
    Spencer, JPE
    Chowrimootoo, G
    Schroeter, H
    Debnam, ES
    Srai, SKS
    Rice-Evans, C
    Hahn, U
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (01) : 212 - 217